NCT03451825
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03451825
Title Phase I/II Study of Avelumab in Pediatric Cancer Subjects
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors EMD Serono Research & Development Institute, Inc.
Indications
Therapies
Age Groups: adult | child
Covered Countries USA | DNK | CAN | BEL

Facility Status City State Zip Country Details
Children's Hospital Colorado Aurora Colorado 80045 United States Details
The Children's Hospital at Montefiore (CHAM) The Bronx New York 10467 United States Details
Cliniques Universitaires Saint-Luc Brussels Belgium Details
UZ Leuven Leuven Belgium Details
Children's Hospital - London Health Sciences Centre London Canada Details
CHU Sainte-Justine Montreal Canada Details
The Hospital for Sick Children Toronto Canada Details
Rigshospitalet Copenhagen Denmark Details
Samsung Medical Center Seoul South Korea Details
Seoul National University Hospital Seoul South Korea Details
Severance Hospital, Yonsei University Seoul South Korea Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field